When we analyzed whether the expression of other PSMD subunits also correlated with OS in AML, patients with elevated levels of PSMD2, PSMD7, and possibly PSMD9 had worse outcomes (Figure 6I–L). This evidence concerns the gene PSMD9 and acute myeloid leukemia.